VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ -- USA News Group - Despite the approval for the Comirnaty vaccine from Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) by the FDA back in August, vaccine hesitancy in the USA persists and is unlikely to disappear. Now with what PFE/BNTX are calling encouraging results for their Covid-19 vaccine trial on kids in hand, it's expected that parents are going to be even more hesitant to jab their own children. Reports of heart inflammation are adding fuel to the fire, spurning closer studies into myocarditis risk taking place inIsrael and the USA, and Canada particularly with mRNA vaccines such as those from Pfizer, BioNTech and Moderna, Inc. (NASDAQ:MRNA), while earlier this year multiple European countries suspended the use of AstraZeneca PLC (NASDAQ:AZN) over worries about blood clots. While these manufacturers are standing by their safety and efficacy, a new study on the hapten-modified spike protein used in the BVX-0320 SARS-CoV-2 vaccine from BioVaxys Technology Corp. (CSE:BIOV) (OTCQB:BVAXF) is giving hope to another method that could potentially mitigate some of these abnormal life-threatening side effects.
Search / 394 results found Showing: 1-10 of 394
NEW YORK, Sept. 23, 2021 /PRNewswire/ -- NYPPEX, one of the world's leading providers of secondary private equity liquidity, today issued a warning about investment risk in China private equity investments. NYPPEX believes that China is entering a new phase of government policies that, in summary, seek to focus on "common prosperity" and Mao Zedong's vision for transitory capitalism. Mao Zedong believed that capitalism was initially only needed to alleviate widespread poverty in China.
NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Statewide public retirement systems are poised to deliver in 2021 the highest investment returns seen this century, according to the annual State of Pensions report from Equable Institute. The analysis finds that these record-breaking investment returns (20.7% on average), will cause unfunded liabilities to decrease to $1.08 Trillion in 2021, from $1.48 Trillion in 2020, bringing the funded ratio to 80.9% - a level last seen in 2008 amid the early days of the financial crisis and Great Recession.
NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Access Technology Ventures, the venture capital and growth technology investment arm of privately held industrial group Access Industries, announced today an additional $300 million purchase of stock of Opendoor Technologies Inc. (NASDAQ: OPEN), a leading digital platform for residential real estate.
New partnership combines the best-in-class expertise of both firms to bring clients an array of new U.S.-listed investment opportunities in the digital asset space
NEW YORK, Sept. 22, 2021 /PRNewswire/ -- Tiger Infrastructure Partners ("Tiger Infrastructure") announced today an agreement to invest in 11:11 Systems ("11:11"), a managed infrastructure services provider, including managed network services, cloud, and security. This will be Tiger Infrastructure's second partnership with the CEO of 11:11 Systems, Brett Diamond. Tiger Infrastructure previously partnered with Diamond through its investment in Hudson Fiber Network (HFN), which culminated in the successful sale of HFN to ExteNet Systems in August 2018.
NEW YORK, Sept. 22, 2021 /PRNewswire-PRWeb/ -- Connectivity Business, the trusted source for satellite and telecom investment news, has launched its new website this week, providing readers with an improved user experience.
TEL AVIV, Israel, Sept. 22, 2021 /PRNewswire/ -- Vesttoo, the marketplace for Life and P&C insurance-based risk transfer and investments, today announced the appointment of industry veteran Daniel Butzbaugh as Vice President, Catastrophe (CAT) Markets. He joins Vesttoo from Stonybrook Capital where he was Vice President and Head of the Industry Loss Warranty (ILW) Desk.